October 16, 2019
The IDSA Board of Directors has approved a new Strategic Plan that will continue to ensure the Society charts a successful, transformative and sustainable path forward.
Read More
Experiencing the post-IDWeek blues? Relieve some of your favorite memories by checking out all three daily recap videos highlighting key moments of the conference that took place Oct. 2-6 in Washington, D.C.
Read More
The deadline for the 2020 IDSA Leadership Institute is fast approaching! Individuals interested in joining a community of ascending infectious diseases and HIV specialists should apply today!
Read More
IDSA achieved a major victory in antibiotic stewardship late last month when the Centers for Medicare and Medicaid Services (CMS) finalized the Medicare Condition of Participation requiring all hospitals to establish antibiotic stewardship programs.
Read More
In this feature, a panel of IDSA members identifies and critiques important new studies in the current literature that have a significant impact on the practice of infectious diseases medicine.
Taking It to Heart: Estimating Excess Heart Age in People Living with HIV, Presentation and Outcome of Cryptococcal Infection According to Predisposing Illness, and What’s the Real Relationship Between Finding S. aureus in the Urine and Bacteremia?
Read More
IDSA member and recent recipient of the IDSA D.A. Henderson Award, Catherine M. Wilfert, MD, FIDSA, will soon receive the North Carolina Award, the state’s highest civilian honor.
Read More
The diverse nature of infectious diseases is not only represented by the broad spectrum of infections we treat but also by the ever-evolving uniqueness of our Society.
Read More
IDSA and HIVMA are committed to the principles of inclusion, diversity, access and equity. As part of its work under the IDA&E Task Force, the IDSA and HIVMA boards of directors recently adopted a policy on discrimination, harassment and bullying.
Read More
With the support of IDSA’s Inclusion, Diversity, Access and Equity Task Force, we are conducting a two-part study to identify and characterize barriers to equitable advancement in academic ID and invite you to participate in a 5-MINUTE SURVEY to further explore this issue.
Read More
In the lead-up to IDWeek 2019, 77 IDSA and HIVMA member advocates took to Capitol Hill on Tuesday, Oct. 1 to educate policymakers about issues impacting their patients and the ID/HIV field and to advocate for IDSA/HIVMA priorities.
Read More
October 1 was the first day of Fiscal Year 2020, but federal programs, including global and domestic ID/HIV programs, are operating at FY2019 funding levels through a Continuing Resolution (CR) signed by President Trump on September 27.
Read More
The National Institute of Allergy and Infectious Diseases convened a half-day stakeholder workshop last month to review its scientific training portfolio and funding mechanisms. The workshop stemmed from a meeting with NIAID and IDSA leadership focused on the early career research pipeline.
Read More
IDSA is proud to announce a new online resource on climate change. This page contains IDSA’s policy statement on climate and ID, letters to Congress, and information and tips for members about how to be more “green” in their individual lives and at their institutions.
Read More
The Centers for Disease Control and Prevention has published an article in the October issue of Pediatrics about acute flaccid myelitis activity in the United States from 2015 to 2017.
Read More
As infectious diseases and HIV experts and epidemiologists from 90 countries gathered in Washington, D.C. for IDWeek 2019, the global IDSA and HIVMA Science Speaks blog was there to cover the event.
Read More
IDSA spokespersons Cesar Arias, MD, FIDSA, and Cornelius Clancy, MD, spoke with Infectious Disease Special Edition on why physicians are slow to use and prescribe new antibiotics.
Read More
Here’s a glance at the latest discussions happening on MyIDSA, IDSA’s members-only online community (login required).
Read More
